Filing Overview
This Form 8-K was filed by Deep Medicine Acquisition Corp. on September 30, 2022, reporting an event occurring September 26, 2022. Although the request identifies Trugolf Holdings, Inc., the filing’s registrant is Deep Medicine Acquisition Corp., a special purpose acquisition company. The filing concerns the termination of its proposed business combination with Chijet Inc. and related parties.
Business Context and Reporting Period
Deep Medicine had entered into a Business Combination Agreement dated July 12, 2022, with Chijet Inc., Chijet Motor Company, Inc., Chijet Motor (USA) Company, Inc., and specified Chijet shareholders. Amendment No. 1 extended the due diligence period to September 20, 2022, and Amendment No. 2 further extended it to September 30, 2022.
Financial and Liquidity Information
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, valuation, or other operating financial metrics.
- The filing states that Deep Medicine was not obligated to pay penalties under the Business Combination Agreement as a result of the termination.
- The filing also states that no penalties were owed under the related Support Agreement.
Material Changes and Transaction Status
- On September 26, 2022, Deep Medicine terminated the Business Combination Agreement by sending termination notices to Chijet and Pubco.
- The termination was made pursuant to Sections 2.2(e), 2.2(f), 11.1(h), and 11.1(i) of the agreement.
- The Support Agreement dated July 12, 2022, among Deep Medicine, Bright Vision Sponsor LLC, Chijet, and Pubco automatically terminated as a result.
- The proposed business combination therefore did not proceed under the disclosed agreement.
Outlook, Risks, and Unusual Items
The filing does not provide new financial guidance or an operating outlook. Forward-looking statements regarding the proposed business combination are subject to customary risks and uncertainties, but the transaction was terminated as of September 26, 2022. The principal unusual item is the termination of the business combination and the automatic termination of the related Support Agreement without stated penalties.
Key Facts for Investors to Verify
- Verify that the applicable registrant is Deep Medicine Acquisition Corp., not Trugolf Holdings, Inc.
- Review the full Business Combination Agreement and Amendments Nos. 1 and 2 to understand the cited termination provisions and any remaining rights or obligations.
- Confirm whether the termination affected the SPAC’s liquidation timeline, trust account, redemption procedures, or future transaction plans; this filing does not provide those details.
- Review subsequent SEC filings for disclosures regarding the SPAC’s status, shareholder actions, operating expenses, and potential liquidation or alternative business combination.